Direxion Daily S&P Biotech Bear 1X ETF (LABS) Analysis

Cette page a été traduite automatiquement de l'original anglais par IA ; la version anglaise fait foi. Lire la version anglaise

À titre informatif uniquement. Ne constitue pas un conseil financier.

Direxion Daily S&P Biotech Bear 1X ETF (LABS) ETF — Price, Holdings & Analysis

Vue d'ensemble de l'ETF

Direxion Daily S&P Biotech Bear 1X ETF provides exposure to the equity market. Direxion Daily S&P Biotech Bear 1X ETF invests across equity markets, providing investors with diversified exposure to this asset class through a single, exchange-traded vehicle. As an exchange-traded fund, it offers the benefits of intraday liquidity, transparent holdings, and generally lower costs compared to traditional mutual fund structures.

Mesures de Risque

As with all ETFs, the fund is subject to market risk and its value will fluctuate with market conditions. Past performance does not guarantee future results. The fund's investment objectives, risks, charges, and expenses may be worth researching before investing.

ARK Innovation ETF (ARKK) — 0.75% expense ratio
State Street Energy Select Sector SPDR ETF (XLE) — 0.08% expense ratio
Invesco QQQ Trust, Series 1 (QQQ) — 0.18% expense ratio
State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) — 0.16% expense ratio
State Street Technology Select Sector SPDR ETF (XLK) — 0.08% expense ratio
WisdomTree Emerging Markets ESG Fund (DVEM) — 0.32% expense ratio
Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) — 0.59% expense ratio
iShares MSCI EAFE ETF (EFA) — 0.32% expense ratio

Direxion Daily Global Clean Energy Bull 2X Shares (KLNE) (Equity) — 1.33% expense ratio
Direxion Daily AMD Bull 2X ETF (AMUU) (Equity) — 1.16% expense ratio
Direxion Daily Uranium Industry Bull 2X ETF (URAA) (Equity) — 1.46% expense ratio
Direxion Russell Small Over Large Cap ETF (RWSL) (Equity) — 0.59% expense ratio
Direxion MSCI Developed Over Emerging Markets ETF (RWDE) (Equity) — 0.53% expense ratio
Direxion Daily XOM Bull 2X ETF (XOMX) (Equity) — 2.36% expense ratio

Questions & Réponses

How long has LABS been around?

Direxion Daily S&P Biotech Bear 1X ETF was launched in 2015, making it 11 years old. With over a decade of history, it has navigated various market conditions.

Is LABS a good investment?

Direxion Daily S&P Biotech Bear 1X ETF is a equity ETF. Equity ETFs are subject to market risk and can experience significant short-term volatility, though they have historically provided strong long-term returns for patient investors.

Whether it is suitable depends on your investment goals, risk tolerance, and time horizon. Consider consulting a financial advisor for personalized guidance.

Avertissement : Ce contenu est fourni à titre informatif uniquement et ne constitue pas un conseil en investissement. Effectuez toujours vos propres recherches et consultez un conseiller financier.

Données fournies à titre informatif uniquement.

Rédigé par une machine, sans relecture page par page. Le contrôle éditorial est systémique : les règles et les sources sont vérifiées, pas chaque page.